Evidence map›Paper›PMID 37960324›Full record

ReviewNutrients2023

Regulation of Macronutrients in Insulin Resistance and Glucose Homeostasis during Type 2 Diabetes Mellitus.

Wanbao Yang, Wen Jiang, Shaodong Guo

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07711587 (A Pilot Study Investigating the Effects of Diaplex Supplementation on Glucose Regulation in Otherwise Healthy Adults With Elevated Blood Glucose Levels), which is not on this map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
12.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07711587 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

A Pilot Study Investigating the Effects of Diaplex Supplementation on Glucose Regulation in Otherwise Healthy Adults With Elevated Blood Glucose Levels

TypeinterventionalSponsorStandard Process Inc.Ran2026 to 2027Enrolled40ConditionsInsulin Sensitivity, Healthy AdultArmsDiaplex, Placebo
3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. A Novel Blend ofFoods (Basel, Switzerland) · 2026
    Article
  7. Article
  8. Article
  9. GLP-1 agonists and the gut microbiome: A bidirectional relationship.British journal of clinical pharmacology · 2026
    Review
  10. Article
  11. Predictors of In-Hospital Mortality in Patients With Type 2 Diabetes Complicated by Isolated Hyperosmolar Hyperglycemic Syndrome.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Wanbao YangDepartment of Nutrition, College of Agriculture and Life Sciences, Texas A&M University, College Station, TX 77843, USA.
Wen JiangDepartment of Nutrition, College of Agriculture and Life Sciences, Texas A&M University, College Station, TX 77843, USA.
Shaodong GuoDepartment of Nutrition, College of Agriculture and Life Sciences, Texas A&M University, College Station, TX 77843, USA.ORCID 0000-0001-5126-731X
Texas A&M University · US

Funding

Hepatic TGFbeta1 in Control of Type 2 Diabetes and NASH via FoxO1 SignalingR01DK124588 · NIDDK · TEXAS A&M AGRILIFE RESEARCH · PI GUO, SHAODONG · 2022 to 2025
$2.0M
Targeting Insulin Resistance by Estrogen Receptor in Control of Type 2 Diabetes MellitusR01DK120968 · NIDDK · TEXAS A&M AGRILIFE RESEARCH · PI GUO, SHAODONG · 2019 to 2022
$1.4M
Transcriptional Regulation of Metabolic and Hepatic Homeostasis by FoxO SignalingR01DK095118 · NIDDK · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI GUO, SHAODONG · 2012 to 2016
$1.4M
NIDDK NIH HHS R01 DK095118NIDDK NIH HHS R01 DK120968NIDDK NIH HHS R01 DK124588NIH HHS R01 DK095118NIH HHS R01 DK120968NIH HHS R01 DK124588
6 · The paper itself

Abstract

Insulin resistance is an important feature of metabolic syndrome and a precursor of type 2 diabetes mellitus (T2DM). Overnutrition-induced obesity is a major risk factor for the development of insulin resistance and T2DM. The intake of macronutrients plays a key role in maintaining energy balance. The components of macronutrients distinctly regulate insulin sensitivity and glucose homeostasis. Precisely adjusting the beneficial food compound intake is important for the prevention of insulin resistance and T2DM. Here, we reviewed the effects of different components of macronutrients on insulin sensitivity and their underlying mechanisms, including fructose, dietary fiber, saturated and unsaturated fatty acids, and amino acids. Understanding the diet-gene interaction will help us to better uncover the molecular mechanisms of T2DM and promote the application of precision nutrition in practice by integrating multi-omics analysis.

Indexed as

Diabetes Mellitus, Type 2Insulin ResistanceGlucoseHomeostasisHumansInsulinNutrientsGlucoseInsulinNutrientsglucose homeostasisinsulin resistancemacronutrientstype 2 diabetes mellitus

Identifiers

PMID37960324
PMCPMC10647592
OpenAlexW4388333696

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.